Effects of Finger Kazoo Exercise With and Without Oropharyngeal Enlargement in the Operatic Singing Voice

NCT ID: NCT07129668

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-30

Study Completion Date

2025-07-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial aimed to evaluate the effects of the semi-occluded vocal tract exercise Finger Kazoo (FK), with and without oropharyngeal expansion, on the singing voice. Fifteen classically trained singers, screened using the Singing Voice Handicap Index-10 (SVHI-10), participated in a randomized, single-blind, crossover trial with two experimental sessions separated by 48 hours. Participants were randomized via Sealed Envelope to start in Condition A (without oropharyngeal expansion) or Condition B (with oropharyngeal expansion). In each session, standardized recordings were obtained before and after the intervention, including maximum phonation time for the vowels /a/ and /i/, and an operatic aria excerpt. Acoustic analysis (PRAAT) extracted fundamental frequency (F0), jitter, and shimmer. Comparisons between baseline and experimental conditions were performed using paired-samples t-tests, Wilcoxon tests, robust paired t-tests, and Friedman ANOVA with Durbin-Conover, Tukey, Bonferroni, and Holm post hoc corrections, with a 95% confidence interval. Auditory-perceptual evaluation was conducted by 15 blinded experts using the EAI Scale Form, with balanced sample distribution among raters. Self-perceptual evaluation was also performed by participants using the same scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Voice Alteration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Fifteen classically trained singers participated in a randomized, single-blind, crossover trial with two experimental sessions separated by 48 hours. Participants were allocated via Sealed Envelope randomization to start in Condition A (without oropharyngeal expansion) or Condition B (with oropharyngeal expansion). In each session, standardised recordings were obtained before and after the intervention, including maximum phonation time for the vowels /a/ and /i/, and an operatic aria excerpt.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Condition A

Without Oropharyngeal Enlargement

Group Type ACTIVE_COMPARATOR

Condition A

Intervention Type BEHAVIORAL

Condition A consists of performing the Finger Kazoo exercise without inducing oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, but without modifying tongue position, soft palate height, or pharyngeal wall expansion to increase the oropharyngeal space.

Condition B

Intervention Type BEHAVIORAL

Condition B consists of performing the Finger Kazoo exercise with intentional oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, while simultaneously modifying tongue position, elevating the soft palate, and expanding the pharyngeal walls to increase the oropharyngeal space.

Condition B

With Oropharyngeal Enlargement

Group Type ACTIVE_COMPARATOR

Condition A

Intervention Type BEHAVIORAL

Condition A consists of performing the Finger Kazoo exercise without inducing oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, but without modifying tongue position, soft palate height, or pharyngeal wall expansion to increase the oropharyngeal space.

Condition B

Intervention Type BEHAVIORAL

Condition B consists of performing the Finger Kazoo exercise with intentional oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, while simultaneously modifying tongue position, elevating the soft palate, and expanding the pharyngeal walls to increase the oropharyngeal space.

Condition 0 or Baseline

Condition 0 (Baseline) consists of producing the target vocal tasks without any semi-occlusion or intentional oropharyngeal modification just a pre vocal warmup.

Group Type ACTIVE_COMPARATOR

Condition A

Intervention Type BEHAVIORAL

Condition A consists of performing the Finger Kazoo exercise without inducing oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, but without modifying tongue position, soft palate height, or pharyngeal wall expansion to increase the oropharyngeal space.

Condition B

Intervention Type BEHAVIORAL

Condition B consists of performing the Finger Kazoo exercise with intentional oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, while simultaneously modifying tongue position, elevating the soft palate, and expanding the pharyngeal walls to increase the oropharyngeal space.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Condition A

Condition A consists of performing the Finger Kazoo exercise without inducing oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, but without modifying tongue position, soft palate height, or pharyngeal wall expansion to increase the oropharyngeal space.

Intervention Type BEHAVIORAL

Condition B

Condition B consists of performing the Finger Kazoo exercise with intentional oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, while simultaneously modifying tongue position, elevating the soft palate, and expanding the pharyngeal walls to increase the oropharyngeal space.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Whitout Oropharyngeal Enlargement With Oropharyngeal Enlargement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Classically trained singers aged 18 to 45 years.
* Scoring below the cutoff for vocal handicap on the Singing Voice Handicap Index-10 (SVHI-10 ≤ 6 )\*.
* No history of recently vocal fold pathology or laryngeal surgery.
* Non-smokers and no current upper respiratory infection.
* Willingness and ability to attend two experimental sessions spaced 48 hours apart.

Exclusion Criteria

* Presence of any current voice disorder or history of chronic laryngeal disease.
* Recent respiratory infection within 2 weeks prior to enrollment.
* Use of medications affecting voice or respiratory function.
* Inability or unwillingness to comply with study protocol.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

School of Health Sciences, University of Aveiro (ESSUA)

UNKNOWN

Sponsor Role collaborator

Aveiro University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jean Carlos Gorges

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Essua - University of Aveiro

Aveiro, Aveiro District, Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

doi.org/10.54499/2023.0361.BD

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

10-CE/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.